Discover how Anthropic's Claude Code Interpreter transforms workflows with AI-powered data analysis, reporting, and ...

Modern PR is becoming an increasingly important element of image building and helps companies not only stand out but also ...

ESCCA As a leading forum for scientific exchange in flow cytometry, ESCCA focuses on clinical applications in hematology, immunology, cancer, and cell biology. ESCCA 2025 will be held in Montpellier, ...

Can the users of financial statements and annual reports rely upon the charts in them for accuracy? A sample of 50 public ...

Abstract: Despite the recent surge of research efforts to make data visualizations accessible to people who are blind or have low vision (BLV), how to support BLV people's data analysis remains an ...

Imagine opening Excel and no longer needing to wrestle with complex formulas or spend hours manually analyzing data. What if you could simply type a question, like “What are the top-performing ...

EdSource · Play and potty training: The realities of California's TK rollout Play and potty training: The realities of California’s TK rollout August 28, 2025 - California schools need a whole new ...

August 11, 2025 - Previous articles in this series have explored identification, preservation, collection, review and production of novel data sources, but I would be remiss if I left out the last, ...

CareDx, Inc. (Nasdaq: CDNA), — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value ...

PHILADELPHIA and VANCOUVER, British Columbia, July 25, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage ...

Go from text prompts to slide decks in minutes with CNET's guide on creating a PowerPoint presentation using artificial intelligence tools. Amanda Smith is a freelance journalist and writer. She ...

– Data from an analysis designed to evaluate the potential effects of the Phase 3 zorevunersen dosing regimen showed improvements in cognition and behavior at Week 68 – – These findings support the ...